Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at


The present invention generally relates to compositions comprising benzonapthyridine small molecule immune potentiators (SMIPs) that are capable of stimulating or modulating an immune response in a subject that has had pre- or post-exposure to a pathogen such as hemorrhagic fever virus. Also provided are methods of preparing and using the SMIP compositions of the invention.

Docket:RIID 11-23

Publication/Issued No.:9,597,326

Publication/Issue Date:2017-03-21

Categories: Therapeutic

More Detail:Visit USPTO.GOVExternal link


Inventor(s):GILLIS, ET AL

For Licensing Opportunities, please contact the ORTA at

Last Modified Date: 25 Jul 2023

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRDC Public Affairs Office at: or by telephone at (301)619-2736.